In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Novartis Vaccines

Division of Novartis AG

Latest From Novartis Vaccines

US Army Splashes The Cash On Valneva's JE Vaccine

Valneva’s 2019 guidance has been boosted by the US Army’s Ixiaro vaccine order, as other products flourish in the pipeline.

Vaccines Deals

European Notebook: Data Transparency And Adaptive Licensing Move Forward

More clinical trials move to Denmark, Sanofi’s Viehbacher moves to Boston, and analysts suggest thwarted Pfizer’s next strategic move may be to use contingent value rights in a future attempt for AstraZeneca, plus more in this month’s notebook.

BioPharmaceutical Europe

Thailand’s BioNet-Asia On Developing Domestic Vaccines – An Interview With PharmAsia News

BioNet-Asia has carved a path in vaccines research in Thailand that faces the hurdle of attracting private funding while working on establishing proof of concept for pertussis and dengue vaccines. A mix of private capital and multinational alliances have helped nations such as Vietnam, Indonesia and Malaysia build up domestic vaccine capabilities.

BioPharmaceutical Thailand

Four-Strain Flu Vaccine Gains Traction With Sanofi’s sBLA Filing

Sanofi’s application for a quadrivalent flu vaccine comes eight months after FDA approved MedImmune’s quadrivalent and seven months after GSK’s filing; companies expect to transition to the four-strain vaccine.

BioPharmaceutical Clinical Trials
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Chiron Vaccines
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Novartis AG
  • Senior Management
  • Contact Info
  • Novartis Vaccines
    Phone: (617) 871-7000
    350 Massachusetts Ave.
    Cambridge, MA 02139